MedPath

Statins and rheumatoid arthritis

Not Applicable
Conditions
Rheumatoid arthritis.
Seropositive rheumatoid arthritis
Registration Number
IRCT138811161778N2
Lead Sponsor
Vice chancellery of research, Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Rheumatoid arthritis patients (proved by ACR criteria) and 3 months passed from their diagnosis.
Exclusion criteria: Drug reaction, lapse from the study, Immigration or death, containdications for statins (pregnancy, lactation, abnormal liver function tests abnormality

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical and laboratory findings. Timepoint: Before the study and 3 months later. Method of measurement: DAS28, ESR, VAS.
Secondary Outcome Measures
NameTimeMethod
Better control of rheumatoid arthritis and prevention of joint destruction. Timepoint: Befor the study and 3 months later. Method of measurement: DAS28, ESR, VAS.
© Copyright 2025. All Rights Reserved by MedPath